<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>105(10)</volume><submitter>Glembotsky AC</submitter><journal>Haematologica</journal><pagination>e535</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7556663</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: correlation with the clinical phenotype.</pubmed_title><pmcid>PMC7556663</pmcid><pubmed_authors>Raslova H</pubmed_authors><pubmed_authors>Glembotsky AC</pubmed_authors><pubmed_authors>Marzac C</pubmed_authors><pubmed_authors>De Luca G</pubmed_authors><pubmed_authors>Marta RF</pubmed_authors><pubmed_authors>Heller PG</pubmed_authors><pubmed_authors>Auger N</pubmed_authors><pubmed_authors>Marin Oyarzun CP</pubmed_authors><pubmed_authors>Goette NP</pubmed_authors></additional><is_claimable>false</is_claimable><name>First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: correlation with the clinical phenotype.</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2026-06-06T22:49:52.579Z</modification><creation>2025-04-05T23:07:45.22Z</creation></dates><accession>S-EPMC7556663</accession><cross_references><pubmed>33054100</pubmed><doi>10.3324/haematol.2020.253070</doi></cross_references></HashMap>